LU85631A1 - Oxazolidine - Google Patents
Oxazolidine Download PDFInfo
- Publication number
- LU85631A1 LU85631A1 LU85631A LU85631A LU85631A1 LU 85631 A1 LU85631 A1 LU 85631A1 LU 85631 A LU85631 A LU 85631A LU 85631 A LU85631 A LU 85631A LU 85631 A1 LU85631 A1 LU 85631A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- phenyl
- compounds according
- formula
- methyl
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH607083 | 1983-11-10 | ||
CH6070/83A CH655931A5 (en) | 1983-11-10 | 1983-11-10 | Oxazolidines |
CH449984 | 1984-09-20 | ||
CH449984 | 1984-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
LU85631A1 true LU85631A1 (fr) | 1986-06-04 |
Family
ID=25695620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU85631A LU85631A1 (fr) | 1983-11-10 | 1984-11-07 | Oxazolidine |
Country Status (22)
Country | Link |
---|---|
US (2) | US4743604A (no) |
AT (1) | AT387771B (no) |
AU (1) | AU576531B2 (no) |
BE (1) | BE900983A (no) |
CA (1) | CA1249992A (no) |
DE (1) | DE3438411A1 (no) |
DK (1) | DK520584A (no) |
ES (1) | ES8606863A1 (no) |
FI (1) | FI844152L (no) |
FR (1) | FR2554814B1 (no) |
GB (1) | GB2149405B (no) |
HU (1) | HU193465B (no) |
IL (1) | IL73427A (no) |
IT (1) | IT1177033B (no) |
LU (1) | LU85631A1 (no) |
MC (1) | MC1641A1 (no) |
NL (1) | NL8403308A (no) |
NO (1) | NO844501L (no) |
NZ (1) | NZ210105A (no) |
PH (1) | PH22462A (no) |
PT (1) | PT79485B (no) |
SE (1) | SE463099B (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988009661A1 (en) * | 1987-06-10 | 1988-12-15 | Pfizer Inc. | Oxazolidin-2-one derivatives as hypoglycemic agents |
FI892341A (fi) * | 1988-06-10 | 1989-12-11 | Hoffmann La Roche | Propanolaminderivat. |
US5321036A (en) * | 1993-02-10 | 1994-06-14 | Bristol-Myers Squibb Company | Thiazole and oxazole-based β3 adrenergic receptor agonists |
US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
SK111195A3 (en) * | 1994-09-13 | 1997-06-04 | Sandoz Technology Ltd | Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same |
US7510849B2 (en) * | 2004-01-29 | 2009-03-31 | Glucolight Corporation | OCT based method for diagnosis and therapy |
US7254429B2 (en) | 2004-08-11 | 2007-08-07 | Glucolight Corporation | Method and apparatus for monitoring glucose levels in a biological tissue |
US8036727B2 (en) | 2004-08-11 | 2011-10-11 | Glt Acquisition Corp. | Methods for noninvasively measuring analyte levels in a subject |
AU2006235535A1 (en) | 2005-04-13 | 2006-10-19 | Glt Acquisition Corp. | Method for data reduction and calibration of an OCT-based blood glucose monitor |
WO2009111542A2 (en) | 2008-03-04 | 2009-09-11 | Glucolight Corporation | Methods and systems for analyte level estimation in optical coherence tomography |
US9784726B2 (en) | 2013-01-08 | 2017-10-10 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatment |
GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA979912A (en) * | 1970-06-22 | 1975-12-16 | Frederic P. Hauck | Tetrahydronaphthyloxyaminopropanols and related compounds |
GB1301134A (en) * | 1970-07-18 | 1972-12-29 | Pfizer Ltd | SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES |
-
1984
- 1984-10-11 CA CA000465149A patent/CA1249992A/en not_active Expired
- 1984-10-19 DE DE19843438411 patent/DE3438411A1/de not_active Withdrawn
- 1984-10-22 FI FI844152A patent/FI844152L/fi not_active Application Discontinuation
- 1984-10-25 IT IT23307/84A patent/IT1177033B/it active
- 1984-10-31 NL NL8403308A patent/NL8403308A/nl not_active Application Discontinuation
- 1984-11-01 DK DK520584A patent/DK520584A/da not_active Application Discontinuation
- 1984-11-01 US US06/667,186 patent/US4743604A/en not_active Expired - Fee Related
- 1984-11-05 IL IL73427A patent/IL73427A/xx unknown
- 1984-11-05 NZ NZ210105A patent/NZ210105A/xx unknown
- 1984-11-06 BE BE0/213953A patent/BE900983A/fr not_active IP Right Cessation
- 1984-11-06 MC MC841735A patent/MC1641A1/xx unknown
- 1984-11-07 LU LU85631A patent/LU85631A1/de unknown
- 1984-11-08 ES ES537487A patent/ES8606863A1/es not_active Expired
- 1984-11-08 FR FR8417009A patent/FR2554814B1/fr not_active Expired
- 1984-11-09 SE SE8405632A patent/SE463099B/sv not_active IP Right Cessation
- 1984-11-09 HU HU844174A patent/HU193465B/hu unknown
- 1984-11-09 PH PH31427A patent/PH22462A/en unknown
- 1984-11-09 AT AT0355384A patent/AT387771B/de not_active IP Right Cessation
- 1984-11-09 NO NO844501A patent/NO844501L/no unknown
- 1984-11-09 PT PT79485A patent/PT79485B/pt unknown
- 1984-11-09 AU AU35275/84A patent/AU576531B2/en not_active Ceased
- 1984-11-09 GB GB08428335A patent/GB2149405B/en not_active Expired
-
1988
- 1988-02-05 US US07/152,522 patent/US4871755A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0101069B1 (de) | Neue Phenäthanolamine | |
EP0140243B1 (de) | Phenoxypropanolamine | |
LU85631A1 (fr) | Oxazolidine | |
EP0254856B1 (de) | Pyridinäthanolaminderivate | |
EP0400011B1 (de) | Neue phenylethanolamine | |
EP0094595B1 (de) | Neue Aziridin- und Phenäthanolaminderivate | |
DE2332837A1 (de) | Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
EP0198412B1 (de) | Phenäthanolaminderivate | |
DE3876846T2 (de) | Morpholinderivate und deren verwendung. | |
AU622907B2 (en) | Propanolamine derivatives | |
DE2633245A1 (de) | 4-hydroxy-1,3-benzoldimethanolverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
EP0013749A1 (de) | Hexahydro-1,4-oxazepine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
DE2404328A1 (de) | Verfahren zur herstellung von alpha(l-aralkylaminoalkyl)-aralkoxybenzylalkoholen | |
AU617353B2 (en) | Pyridylethanolamines | |
DE2644972A1 (de) | Thiaprostaglandine | |
DE1518334C3 (de) | Substituierte Benzylamme und ihre Salze sowie Verfahren zu ihrer Herstellung | |
CH655931A5 (en) | Oxazolidines | |
DE2743493A1 (de) | Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel | |
EP0386603A2 (de) | Bisphenäthanolamine | |
KR820002065B1 (ko) | 펜에탄올 아민류의 제조방법 | |
AT353272B (de) | Verfahren zur herstellung von neuen piperidin- derivaten sowie von deren salzen und optisch aktiven formen | |
AT371101B (de) | Verfahren zur herstellung neuer optisch aktiver phenethanolamine und der pharmazeutisch unbedenklichen salze hiervon | |
DE3025325A1 (de) | Neue 13-thiaprostaglandin-zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von 13-thiaprostaglandin-derivaten | |
DE1768366B2 (de) | 3-hydroxy-alpha-(1-aminoaethyl)benzylalkohol-derivate und diese enthaltende arzneimittel | |
DE2411640A1 (de) | Verfahren zur herstellung von neuen polycyclischen aminen |